News and Press Releases

ENA Respiratory Successfully Completes Phase Ib Dosing of Antiviral Host Defense Immune Enhancer INNA-051 Dry Powder Formulation in Older Adults and Advances Study in Young Adults  

New intranasal formulation with significantly improved stability was well-tolerated and led to local activation of innate immune pathways in adults aged >60 U.S. Department of Defense (DOD) funded study extension...

Category: Clinical Trials, Drug Delivery
Posted: January 29, 2025

Viroclinics-DDL Changes Name to Cerba Research

14 March 2024 -- Rotterdam, the Netherlands -- Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), a world leading vaccine and antiviral specialty laboratory providing research and clinical trial...

Category: Biotechnology, Clinical Trials
Posted: March 15, 2024

Klaartestraat 20, 9052 Ghent, Belgium